We are the first open-ended fund aimed at exposure to firms focused on the medical and therapeutic application of psilocybin.

With a team of legal advisors, traders and medical experts we aim to open the market for interested investors. Not only because of the potential of high returns, but also to help advance this exciting field of medicine.